{"id":"NCT02426125","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients With Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After Platinum-Based Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07-13","primaryCompletion":"2017-04-21","completion":"2022-07-26","firstPosted":"2015-04-24","resultsPosted":"2019-03-08","lastUpdate":"2023-08-21"},"enrollment":530,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Urothelial Carcinoma"],"interventions":[{"type":"DRUG","name":"Ramucirumab","otherNames":["LY3009806"]},{"type":"DRUG","name":"Docetaxel","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ramucirumab + Docetaxel","type":"EXPERIMENTAL"},{"label":"Placebo + Docetaxel","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to evaluate the safety and efficacy of the study drug ramucirumab in combination with docetaxel in participants with urothelial cancer who failed prior platinum-based therapy.","primaryOutcome":{"measure":"Progression Free Survival (PFS)","timeFrame":"Randomization to Radiological Disease Progression or Death from Any Cause (Up to 18 Months)","effectByArm":[{"arm":"Ramucirumab + Docetaxel","deltaMin":4.07,"sd":null},{"arm":"Placebo + Docetaxel","deltaMin":2.76,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0118"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":13},"locations":{"siteCount":141,"countries":["United States","Australia","Belgium","Canada","Denmark","France","Germany","Greece","Hungary","Israel","Italy","Japan","Mexico","Netherlands","Poland","Romania","Russia","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["35388003","34795131","33160359","31753727","28916371"],"seeAlso":["https://trials.lilly.com/en-US/trial/97404"]},"adverseEventsSummary":{"seriousAny":{"events":111,"n":258},"commonTop":["Fatigue","Alopecia","Decreased appetite","Diarrhoea","Anaemia"]}}